Brief: Zylox-Tonbridge Medical Technology Says NMPA Granted Marketing Approval For Neurovascular Embolization Coils In China
27/09/2021 15:49
Sept 27 (Reuters) - Zylox-Tonbridge Medical Technology Co Ltd 2190.HK :
* ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY - NMPA GRANTED MARKETING APPROVAL FOR
NEUROVASCULAR EMBOLIZATION COILS IN CHINA
Source text for Eikon: ID:nHKS8Z9fG5
Further company coverage: 2190.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY
See all newsChinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansion
Brief: Zylox-Tonbridge Medical Technology Profit For Year Rmb244.4 Mln
Brief: Zylox-Tonbridge Medical Technology Sees Revenue More Than RMB1.05 Billion For Year
Brief: Zylox-Tonbridge Medical Technology Announces Acquisition Of 49% Stake in Optimed Holding GmbH
Brief: Zylox-Tonbridge Medical Technology Recommends Distribution Of Final Dividend Of RMB0.1 Per Share